Cargando…
Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response
The therapeutic activation of antitumour immunity by immune checkpoint inhibitors (ICIs) is a significant advance in cancer medicine, not least due to the prospect of long-term remission. However, many patients are unresponsive to ICI therapy and may experience serious side effects; companion biomar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225330/ https://www.ncbi.nlm.nih.gov/pubmed/35743743 http://dx.doi.org/10.3390/jpm12060958 |